In our news wrap Tuesday, the government of Afghanistan began releasing Taliban prisoners, simultaneously urging the militant group to extend a three-day cease-fire. Dozens of inmates walked out of a jail near Kabul as part of the deal the U.S.
Medicare recipients will be able to get prescription plans that limit copays for insulin, a potential savings of hundreds of dollars, the White House announced Tuesday in a pivot to pocketbook issues that could influence November's election.
By Ricardo Alonso-Zaldivar, Associated Press
Insulin is a vital drug that some 7.4 million Americans must take daily to manage their diabetes. But its price nearly doubled from 2012 to 2016, leaving some patients with no choice but to turn to black-market drugs or traveling…
By Sarah Varney
Rising insulin prices are once again shining an uncomfortable spotlight on drug-company CEOs, who have been dutifully taking a public pounding before congressional committees.
By Philip Moeller
By Bram Sable-Smith, Side Effects Public Media
The price of insulin in the U.S. has more than doubled since 2012 alone. That’s put the lifesaving hormone out of reach for some people with diabetes.
By Emily Kopp, Kaiser Health News
The cost of insulin medications has steadily risen over the past decade by nearly 300 percent.
By Ed Silverman, STAT
In his latest attack on the pharmaceutical industry, Senator Bernie Sanders has asked the Department of Justice and the Federal Trade Commission to investigate three insulin makers for price collusion.
By Rebecca Robbins, STAT
The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of a shakeup.
By Andrew Stelzer, KQED
Counter Culture Labs has about 35 dues-paying members and dozens of volunteers. Aside from the insulin project, the DIY scientists are trying to make vegan cheese.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.